RACGP Top End visit an ‘important step’ College leaders are travelling to remote parts of the NT this week ahead of next year’s transition to profession-led training.
Semaglutide unavailable in Australia until April 2023 GPs have been told not to initiate any new patients on either semaglutide or dulaglutide, which will also only have ‘limited availability’.
Vast majority of Australian population has had COVID: Seroprevalence survey Upwards of eight in 10 people have at some point likely contracted the disease, which is now the third leading cause of death nationwide.
Survey hints at increasing long COVID burden Half of the nearly 2200 people surveyed by Lung Foundation Australia reported ongoing symptoms more than four weeks after their initial infection.
New variants expected to supplant BA.5 in Australia Both XBB and BQ.1 possess a growth advantage over previous COVID strains, but there is no evidence to suggest either variant is more severe.
Diabetes medication shortage worsens There is not expected be enough dulaglutide in Australia to fill all prescriptions for type 2 diabetes patients until at least early 2023, the TGA has warned.
Budget: Promises kept but reform needed The Federal Budget fulfils election commitments but does not address the major challenges facing general practice, the RACGP has said.
GP provider details compromised in Medibank leak Australia’s largest health insurer says it has not yet determined the extent of the breach, with the AFP now also becoming involved.
Readers reject alleged scale of Medicare leakage Only one in 10 respondents to a newsGP poll believe the reported $8 billion estimate is accurate.
TGA approves Moderna as adolescent booster An ongoing study demonstrates that the booster produces a similar immune response in this cohort to adults aged 18–25, the regulator says.